All Roll Calls
Yes: 132 • No: 0
Sponsored By: Missy Irvin (Republican), Lee Johnson (Republican)
Enacted
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Arkansas healthcare providers can appeal drug payments below their documented cost to buy the drug. Insurers and entities contracting for them must allow at least 60 business days after a claim decision to appeal. Providers can submit appeals directly to the insurer or plan, with contact options provided. The contracting entity must respond within 30 business days. A denial must explain the specific reason and identify any additional information needed to prove the drug's cost. A successful appeal requires payment of at least 110% of the provider's documented purchase cost. The entity must reprocess the disputed claim and later claims for the same drug, identified by standard drug or billing codes. The rate lasts through the current fiscal quarter when the appeal is filed before that quarter's last month. Appeals filed in the last month receive that rate through the following fiscal quarter. Providers can also send quarterly lists of drugs costing more than contracted payments. The entity can then raise payments to at least 110% of purchase cost, but this step is optional. The law covers drugs, biological products, and related medical supplies, but excludes services paid through licensed pharmacy benefits managers. It also excludes dental-only, vision-only, disability-income, credit, specified supplemental or limited-benefit, certain workers' compensation, and nonfederal governmental plans. The law does not directly change patients' copays, premiums, or benefits.
Missy Irvin
Republican • Senate
Lee Johnson
Republican • House
There are no cosponsors for this bill.
All Roll Calls
Yes: 132 • No: 0
Senate vote • 4/8/2025
Senate Vote - Tuesday, April 8, 2025 9:19:10 PM
Yes: 34 • No: 0
House vote • 3/31/2025
House Vote - Monday, March 31, 2025 2:06:29 PM
Yes: 98 • No: 0
Notification that HB1703 is now Act 570
Correctly enrolled and ordered transmitted to the Governor's Office.
TO BE ENROLLED
Returned from the Senate as passed.
Returned to the House as passed.
Read the third time and passed.
Returned by the Committee, with the recommendation that it Do Pass
Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
Received from the House.
Read the third time and passed and ordered transmitted to the Senate.
Returned by the Committee Do Pass
REPORTED CORRECTLY ENGROSSED
Amendment No. 1 read and adopted and the bill ordered engrossed.
Placed on second reading for the purpose of amendment.
Read the first time, rules suspended, read the second time and referred to the Committee on INSURANCE & COMMERCE- HOUSE
Filed
HB1703 - Introduced
3/6/2025
Act Version
HB1265, AN ACT FOR THE UNIVERSITY OF ARKANSAS AT LITTLE ROCK APPROPRIATION FOR THE 2025-2026 FISCAL YEAR.
HB1237, TO PROHIBIT MEDICAL PROFESSIONALS FROM SOLICITING INJURED INDIVIDUALS; AND TO SET PENALTIES FOR A VIOLATION OF THE PROHIBITION OF SOLICITATION OF INJURED INDIVIDUALS.
HB1686, TO AMEND THE LAW CONCERNING LICENSES TO CARRY CONCEALED HANDGUNS.
SB440, TO AMEND THE LAW CONCERNING EMBALMERS AND FUNERAL DIRECTORS; TO REGULATE THE USE OF ALKALINE HYDROLYSIS; AND TO REGULATE ALKALINE HYDROLYSIS FACILITIES.
HB1695, TO CLARIFY THE FORECLOSURE PROCESS FOR PROPERTY SUBJECT TO A MUNICIPAL LIEN; TO ALLOW A MUNICIPALITY TO PETITION TO SET ASIDE THE SALE OF PROPERTY TO CERTAIN PERSONS; AND TO PROVIDE FOR THE PRIORITY OF UNRECORDED MUNICIPAL LIENS.
HR1012, TO AMEND THE RULES OF THE HOUSE OF REPRESENTATIVES OF THE NINETY-FIFTH GENERAL ASSEMBLY; TO REQUIRE THAT A MEMBER OF THE HOUSE OF REPRESENTATIVES BE SELECTED AS A DESIGNATED SURVIVOR.